ArticleFrontiers in endocrinology2025
Risk factors for predicting lateral lymph node metastasis of papillary thyroid carcinoma based on LASSO-logistic regression.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Risk factors for lateral and skip lymph node metastasis in adolescents and young adults with papillary thyroid carcinoma.Gland surgery · 2026Article
- Internal validation of a residual thyroid recurrence model after PTC.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Many clinicians are facing the dilemma about whether therapeutic lateral lymph node dissection (LLND) should be applied to treat papillary thyroid carcinoma (PTC) patients with suspicious lateral lymph node metastasis (LLNM). This research plans to construct a model to predict the risk of LLNM in PTC patients. Methods: 389 PTC patients meeting the requirements were retrieved from the database of our hospital. The patients included were randomly divided into the training set (N1 = 244) and the validation set (N2 = 145). LASSO regression and logistic regression were used to screen the risk factors of LLNM. Receiver operating characteristic (ROC) curve, calibration curve and decision curve analysis (DCA) were used to measure the performance of the predictive model. Results: In this study, a predictive model for LLNM in PTC patients was established based on LASSO and logistic regression models. Nomogram was established for visualization. The analyses of the area under the curve (AUC), calibration curve and decision curve of the training set and validation set all performed well, indicating that the prediction model has net benefit and clinical practicability. Conclusions: Nomogram based on LASSO regression can predict the risk of preoperative LLNM in PTC patients. This model can assist doctors in formulating individualized postoperative follow-up plans for PTC patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.